Last reviewed · How we verify
NCT06350734
Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
trial testing Non-Interventional Study in Stage 0a Bladder Cancer AJCC v8 in 204 participants. Participants enrolled and being followed up; not accepting new ones.
31 January 2029
Quick facts
| Lead sponsor | Mayo Clinic |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 204 |
| Start date | 12 October 2018 |
| Primary completion | 31 January 2029 |
| Estimated completion | 31 January 2029 |
| Sites | 3 locations across United States |
Drugs / interventions tested
- Non-Interventional Study (non-interventional-study) — full drug profile →
Conditions studied
- Stage 0a Bladder Cancer AJCC v8 — all drugs for Stage 0a Bladder Cancer AJCC v8 →
- Stage 0is Bladder Cancer AJCC v8 — all drugs for Stage 0is Bladder Cancer AJCC v8 →
- Stage I Bladder Cancer AJCC v8 — all drugs for Stage I Bladder Cancer AJCC v8 →
- Stage II Bladder Cancer AJCC v8 — all drugs for Stage II Bladder Cancer AJCC v8 →
Sponsor
Mayo Clinic
Who can join
18 and older, any sex, with Stage 0a Bladder Cancer AJCC v8 or Stage 0is Bladder Cancer AJCC v8. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates the effect of bladder cancer treatment on quality of life.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06350734
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Non-Interventional Study
Trials testing the same drug.
- NCT07221656 — Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration · not yet recruiting
- NCT07412002 — Quality of End-of-Life Care for Children With Cancer · not yet recruiting
- NCT06607874 — Self-Collection for Cervical Cancer Screening and HPV Vaccination for Cancer Prevention Among Women in Emergency Care in · not yet recruiting
- NCT07235501 — Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hemato · not yet recruiting
- NCT06630338 — Use of Shear Wave Elastography for Intraoperative Brain and Tumor Stiffness Measurements · not yet recruiting
Other recruiting trials for Stage 0a Bladder Cancer AJCC v8
Currently open trials in the same condition.
- NCT07302230 — Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Amon · NA · recruiting
- NCT06733363 — A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscl · Phase 2 · recruiting
- NCT07000084 — Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Inva · Phase 3 · recruiting
- NCT06704191 — In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial · Phase 1, PHASE2 · recruiting
- NCT04164082 — Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabin · Phase 2 · active not recruiting
Other Mayo Clinic trials
Trials by the same sponsor.
- NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men · NA · not yet recruiting
- NCT07221656 — Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration · not yet recruiting
- NCT06891001 — The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, · NA · not yet recruiting
- NCT07169799 — Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE) · NA · recruiting
- NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06350734 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mayo Clinic
- Last refreshed: 17 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06350734.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing